ERBB2 and breast cancer: found that the delivery of HER2-targeted CAR-T cells to the brain led to a strong antitumor function in breast cancer with brain metastases by the orthotopic xenograft model, which solved the difficulty of drugs breaking through the blood-brain barrier in tumor brain metastasis (39).